These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 8052966

  • 21. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K.
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [Abstract] [Full Text] [Related]

  • 22. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
    Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF.
    Cancer Res; 1988 Oct 01; 48(19):5539-45. PubMed ID: 3416307
    [Abstract] [Full Text] [Related]

  • 23. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro.
    Stahl A, Mueller BM.
    Cancer Res; 1994 Jun 01; 54(11):3066-71. PubMed ID: 8187097
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 01; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 26. Role of activated protein C in facilitating basement membrane invasion by tumor cells.
    Kobayashi H, Moniwa N, Gotoh J, Sugimura M, Terao T.
    Cancer Res; 1994 Jan 01; 54(1):261-7. PubMed ID: 8261450
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
    Zheng M, Lu R, Che X, Li J, Zhou C, Wang L, Xu Q, Cao H, Li Q, Yao Z.
    Oncology; 2006 Jan 01; 70(6):418-26. PubMed ID: 17245103
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor.
    Esumi N, Fan D, Fidler IJ.
    Cancer Res; 1991 Sep 01; 51(17):4549-56. PubMed ID: 1873799
    [Abstract] [Full Text] [Related]

  • 31. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
    Pass J, Jögi A, Lund IK, Rønø B, Rasch MG, Gårdsvoll H, Lund LR, Ploug M, Rømer J, Danø K, Høyer-Hansen G.
    Thromb Haemost; 2007 Jun 01; 97(6):1013-22. PubMed ID: 17549305
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B.
    Kobayashi H, Ohi H, Sugimura M, Shinohara H, Fujii T, Terao T.
    Cancer Res; 1992 Jul 01; 52(13):3610-4. PubMed ID: 1617632
    [Abstract] [Full Text] [Related]

  • 33. Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells.
    Nakanishi H, Oguri K, Takenaga K, Hosoda S, Okayama M.
    Lab Invest; 1994 Mar 01; 70(3):324-32. PubMed ID: 7511714
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator.
    Huang HY, Jiang ZF, Li QX, Liu JY, Wang T, Zhang R, Zhao J, Xu YM, Bao W, Zhang Y, Jia LT, Yang AG.
    Cancer Invest; 2010 Aug 01; 28(7):689-97. PubMed ID: 20636107
    [Abstract] [Full Text] [Related]

  • 35. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Plasmin modulators, aprotinin and anti-catalytic plasmin antibody, efficiently inhibit destruction of bovine vascular endothelial cells by choriocarcinoma cells.
    Sugimura M, Kobayashi H, Terao T.
    Gynecol Oncol; 1994 Mar 20; 52(3):337-46. PubMed ID: 7512520
    [Abstract] [Full Text] [Related]

  • 38. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.
    Lakka SS, Rajagopal R, Rajan MK, Mohan PM, Adachi Y, Dinh DH, Olivero WC, Gujrati M, Ali-Osman F, Roth JA, Yung WK, Kyritsis AP, Rao JS.
    Clin Cancer Res; 2001 Apr 20; 7(4):1087-93. PubMed ID: 11309361
    [Abstract] [Full Text] [Related]

  • 39. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L.
    Cancer Res; 2000 Oct 15; 60(20):5848-56. PubMed ID: 11059782
    [Abstract] [Full Text] [Related]

  • 40. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX, Xia YH, Xue TC, Zhang H, Ye SL.
    Oncol Rep; 2011 Mar 15; 25(3):803-8. PubMed ID: 21174062
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.